Literature DB >> 16427636

Human RELMbeta is a mitogenic factor in lung cells and induced in hypoxia.

Aparna Renigunta1, Christiane Hild, Frank Rose, Walter Klepetko, Friedrich Grimminger, Werner Seeger, Jörg Hänze.   

Abstract

RELMbeta (resistin-like molecule) represents the most related human homologue of mouse RELMalpha, also known as hypoxic-induced mitogenic factor (HIMF). In this study, we isolated RELMbeta cDNA from human lung tissue and performed regulatory and functional expression studies. RELMbeta mRNA was upregulated in hypoxia in human lung A549 cell line as well as primary cultured adventitial fibroblasts and smooth muscle cells (SMC) of pulmonary arteries. Upon transfection of a RELMbeta encoding expression plasmid into these cells, we observed significant induction of proliferation particularly in SMC and A549 cells, which could be blocked by phosphatidyl-inositol 3-kinase (PI3K) inhibitors LY294002 and wortmannin. The results suggest that human RELMbeta may contribute to hypoxic-induced pulmonary vascular remodeling processes or hypoxia related fibrotic lung disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16427636     DOI: 10.1016/j.febslet.2006.01.012

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  22 in total

1.  Plasma levels of resistin-like molecule beta in humans.

Authors:  Andrew P Neilson; Zora Djuric; Susan Land; Ikuko Kato
Journal:  Cancer Epidemiol       Date:  2010-11-19       Impact factor: 2.984

2.  Effects of resistin-like molecule β over-expression on gastric cancer cells in vitro.

Authors:  Li-Duan Zheng; Chun-Lei Yang; Teng Qi; Meng Qi; Ling Tong; Qiang-Song Tong
Journal:  World J Gastroenterol       Date:  2012-02-28       Impact factor: 5.742

3.  Absence of bacterially induced RELMbeta reduces injury in the dextran sodium sulfate model of colitis.

Authors:  Laila D McVay; Sue A Keilbaugh; Tracie M H Wong; Sonja Kierstein; Marcus E Shin; Michael Lehrke; Martina I Lefterova; D Edward Shifflett; Sean L Barnes; Fabio Cominelli; Steven M Cohn; Gail Hecht; Mitchell A Lazar; Angela Haczku; Gary D Wu
Journal:  J Clin Invest       Date:  2006-10-05       Impact factor: 14.808

4.  FIZZ2/RELM-β induction and role in pulmonary fibrosis.

Authors:  Tianju Liu; Hyun Ah Baek; Hongfeng Yu; Ho Jin Lee; Byung-Hyun Park; Matthew Ullenbruch; Jianhua Liu; Taku Nakashima; Yoon Young Choi; Gary D Wu; Myoung Ja Chung; Sem H Phan
Journal:  J Immunol       Date:  2011-05-20       Impact factor: 5.422

5.  Interleukin 13- and interleukin 17A-induced pulmonary hypertension phenotype due to inhalation of antigen and fine particles from air pollution.

Authors:  Sung-Hyun Park; Wen-Chi Chen; Nafiseh Esmaeil; Benjamin Lucas; Leigh M Marsh; Joan Reibman; Gabriele Grunig
Journal:  Pulm Circ       Date:  2014-12       Impact factor: 3.017

Review 6.  Obesity-associated cancer risk: the role of intestinal microbiota in the etiology of the host proinflammatory state.

Authors:  Zora Djuric
Journal:  Transl Res       Date:  2016-07-28       Impact factor: 7.012

7.  Hypoxia-induced mitogenic factor (HIMF/FIZZ1/RELMalpha) induces the vascular and hemodynamic changes of pulmonary hypertension.

Authors:  Daniel J Angelini; Qingning Su; Kazuyo Yamaji-Kegan; Chunling Fan; John T Skinner; Hunter C Champion; Michael T Crow; Roger A Johns
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-01-09       Impact factor: 5.464

Review 8.  Resistin family proteins in pulmonary diseases.

Authors:  Qing Lin; Roger A Johns
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-06-17       Impact factor: 5.464

9.  Found in inflammatory zone 1 induces angiogenesis in murine models of asthma.

Authors:  Yan Sun; Jinrong Wang; Huabing Li; Xiuzhen Han
Journal:  Lung       Date:  2008-08-29       Impact factor: 2.584

10.  Resistin-like molecule-beta in scleroderma-associated pulmonary hypertension.

Authors:  Daniel J Angelini; Qingning Su; Kazuyo Yamaji-Kegan; Chunling Fan; Xingwu Teng; Paul M Hassoun; Stephen C Yang; Hunter C Champion; Rubin M Tuder; Roger A Johns
Journal:  Am J Respir Cell Mol Biol       Date:  2009-02-27       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.